◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksIBM › EBITDA

International Business Machines (IBM) EBITDA 2006–TTM

DATA UPDATED 2026-07-12

International Business Machines annual ebitda for fiscal TTM was $17.6 billion, an increase of 2.0% from $17.3 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

IBM Annual EBITDA

EBITDA (annual)TTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
EBITDA$17.6B$17.3B$12.2B$7.5B$7.2B$13.4B$12.7B$14.6B$16.5B$16.6B$17.3B$20.3B$25.0B$25.3B$27.7B$26.2B$24.9B$23.5B$22.8B$20.3B$18.6B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IBM Quarterly EBITDA

EBITDA (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
EBITDA$3.1B$5.9B$4.2B$4.4B$2.8B$4.8B$895M$3.8B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More IBM metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding

All IBM financial statements → Interactive IBM charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.